Greyrock retains its equity investment following the merger of Chromaflo Technologies with CPS Color, Inc.
Greyrock provides Arsenal Capital $9.25 million in subordinated debt and equity to back its acquisition of Flowchem, a producer of pipeline drag reducing agents that significantly reduce turbulent flow and pipeline pressure while increasing throughput.
Greyrock provides $10.2 million of subordinated debt and equity to support Saugatuck Capital’s acquisition of Advanced Printed Circuit Technology, a leading quick-turn manufacturer and fabricator of short-cycle, multi-layer printed circuit boards for the military, medical, telecom, test & measurement and industrial segments.
Greyrock provides Horizon Holdings, LLC $5.5 million in subordinated debt and equity to back its recapitalization of Healthy Food Ingredients. As Healthy Food Ingredients is a leading a processor and supplier of premium non-GMO, organic and gluten-free food ingredients.
Greyrock’s Fund II exits its investment in SoftWriters, a leading provider of management technology for institutional pharmacy providers.
Greyrock’s Fund I exits its investment in Turbonetics, a manufacturer of turbochargers and related components for the automotive performance aftermarket as well as industrial pressure regulators for controlling multi-stage turbocharger installations on natural gas and diesel fired stationary power generators.
Greyrock provides $8.0 million of subordinated debt and equity to support Long Point Capital’s acquisition of Precision Products Group, a leading manufacturer of customized small diameter paper and plastic tubes used in a variety of niche applications requiring tight tolerances, unique materials, robust performance attributes, or difficult to produce shapes.
Greyrock provides Shore Points Capital with subordinated debt and equity to back its recapitalization of Colyar Consulting Group. Colyar is a leading provider of software and services to enable states to manage their federal child nutrition programs.
Greyrock provides $6.0 million of subordinated debt and equity to support Lakeview Equity Partners LLC and industry veterans Kevin Mehring and Dr. Greg Leyers’ acquisition of UAS Laboratories (“UAS”). UAS is a pioneer in the research, development and manufacture of probiotic nutritional supplements.
Greyrock Capital Group announces the first close for GCG Investors III, LP, its third independently managed fund.